Delahaye
Bruno Delahaye, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20140279784 | PARTIAL PREDICTIVE MODELING - A computerized method disclosed herein for analyzing data based on multiple disparate datasets generates a unified predictive model based on a unified dataset, wherein the unified dataset includes data from the multiple disparate datasets. The unified predictive model is partitioned into a number of partial predictive models. A number partial predictions are generated by applying each of the partial predictive models to data from each of the plurality of datasets and the plurality of partial predictions are combined to generate a unified prediction. | 09-18-2014 |
Franck Delahaye, Vorstatettan DE
Patent application number | Description | Published |
---|---|---|
20110097160 | METHOD AND APPARATUS FOR THE TRANSPORTING OF OBJECTS - The present invention relates to methods and apparatuses for the transporting of substantially flat, freely movable objects, wherein at least the holding and guiding takes place by use of a streaming liquid. | 04-28-2011 |
Franck Delahaye, Vorstetten DE
Patent application number | Description | Published |
---|---|---|
20080233760 | Process for the Treatment of Substrate Surfaces - The present invention relates in general terms to the treatment or processing of substrate surfaces. In particular, the invention relates to processes for modifying the surface of silicon wafers. | 09-25-2008 |
Nicolas Delahaye, La Hulpe BE
Patent application number | Description | Published |
---|---|---|
20130052160 | COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT - The present invention relates to the fields of genetics, immunology and medicine. The present invention more specifically relates to in vitro or ex vivo methods for determining the susceptibility to a cancer treatment of a subject having a tumour. These methods comprise a step of determining the ability of the treatment, of the subject and/or of the tumour to induce an anticancer immune response, the inability of at least one of the treatment, the subject and the tumor to induce an anticancer immune response being indicative of a resistance of the subject to the therapeutic treatment of cancer. Inventors in particular identify genes specific of a human subject or of cancerous cells which can be used to predict or assess the sensitivity of a subject to a treatment of cancer. The invention also relates to particular compounds capable of activating or enhancing the immune system of a particular subject, when the subject is exposed to a therapeutic treatment of cancer or before such an exposition. It further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The present invention in addition provides kits, methods for selecting a compound of interest, as well as pharmaceutical compositions and uses thereof. | 02-28-2013 |